Search Empire State Ride

Reach a Fundraising Milestone, Receive a Rider Reward

While fundraising is thrilling, it can also be quite challenging. Our Empire State Riders are champions when it comes to raising funds. We appreciate all the time, effort and energy they put into fundraising to change the state of cancer research for good.

Because we’re so grateful, we wanted to offer you Fundraising Rewards! When you reach a fundraising milestone, you’ll receive a special reward.

Rider Rewards 2018

The team behind the Empire State Ride really appreciates all the efforts you put into fundraising. You’re impacting the future of cancer research and saving lives. The funds raised by our riders support cutting-edge cancer research at the America’s first cancer center, Roswell Park Comprehensive Cancer Center, which provides treatment and care for more than 36,000 patients from 46 states and three foreign countries each year. Thank you!

  • Unfamiliar with The Ride For Roswell? It’s a charity bike ride throughout Buffalo, NY. Routes range from 3 to 102 miles. You’ll also receive free registration and your fundraising minimum waiver for The Ride For Roswell when you reach the Empire State Ride fundraising minimum. Learn more about The Ride here.

  • The Extra Club Member is for Ride For Roswell riders who raise $1,000 or more. There are many benefits to becoming an EMC, such as riding in The Peloton, a catered tent for EMC members only, an invitation to the Above & Beyond Celebration in the fall and more. By raising $5,000 for #ESR18, you’ll automatically become a 2018 EMC Ride For Roswell rider.

  • This custom ESR travel bag will tote all your gear whether you’re hitting the trails, commuting to work, or traveling. It’s constructed from durable, water-repellent snow fabric so all your belongings will stay safe and dry. With a laptop and tablet sleeve, secret stash pouches, RFID-lined pocket, this bag has you covered in any situation.

  • Details to come on the keepsake!

Exploring a New Way to Attack Cancer, Thanks to Donor Support

There’s a new strategy being tested at Roswell Park Comprehensive Cancer Center that delivers a two-pronged attack against cancer cells by super-charging the immune system. Developed at Roswell Park, this therapy is being studied through a phase 1 clinical trial.
“Cancer cells are really smart,” observes Richard Koya, MD, PhD. “Chemotherapy, radiotherapy, surgery and even some immunotherapies may have some effect initially, but cancer cells have a way to evade them, to be resistant and grow back. That’s why it’s so difficult to treat cancer.”
As Associate Director of the Center for Immunotherapy and Director of the Vector Development and Production Facility, Dr. Koya spends a lot of time thinking about ways to help the human immune system outsmart cancer. He developed this new immunotherapy with Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director of Roswell Park and Executive Director of the Center for Immunotherapy.
“What we see over and over in trying to treat some of the most aggressive and intractable cancers, including many lung, brain, ovarian, breast, melanoma and sarcoma tumors, is that the tumor fights back,” says Dr. Odunsi. “We have identified a major pathway by which these kinds of cells try to disable immune cells, and formulated a strategy for exploiting that weakness.”

Super Immune Cells

In a process similar to donating blood, a patient’s T lymphocytes (T cells) are collected and sent over to Roswell Park’s Center for Immunotherapy.
There, they are armed with receptors that enable the T cells to hunt down and destroy specific tumor cells. They’re also given a second gene to protect the T cells from attack by a protein tumors use for protection. Then, the T cells are infused back into the patient and get to work fighting cancer.
“Nobody else is doing the combination of these two different elements in the same platform anywhere in the United States or even on the planet,” says Dr. Koya.
This trial was made possible thanks to Roswell Park donations and funding from the National Institutes of Health.